Bart Claes is currently the Director of Assay Development at iTeos Therapeutics, a position they have held since 2022. They previously worked as a Lead Scientist and Principal Scientist at miDiagnostics from 2021 to 2022. Before that, Bart served as a Senior Scientist, Scientist, and Principal Scientist at Biocartis from 2015 to 2021.
Location
Leuven, Belgium
This person is not in any teams
This person is not in any offices